Abstract
Recent PET imaging of glioblastoma multiforme and other high-grade gliomas using prostate-specific membrane antigen (PSMA)-targeted small-molecule radiotracers suggests a role for these agents in diagnostic imaging of recurrent/residual tumor and that PSMA-targeted endoradiotherapies may provide a new approach to therapy for patients with these difficult-to-treat tumors. We present a case of cerebral radionecrosis demonstrating PSMA-targeted radiotracer uptake. Our findings may represent a potential pitfall and limitation to the diagnostic application of PSMA-targeted agents for high-grade gliomas.
Original language | English |
---|---|
Pages (from-to) | e419-e421 |
Journal | Clinical Nuclear Medicine |
Volume | 43 |
Issue number | 11 |
DOIs | |
State | Published - 1 Nov 2018 |
Externally published | Yes |
Keywords
- glioblastoma multiforme
- positron emission tomography
- prostate-specific membrane antigen